Kyntra Bio files 8-K on delisting notice or failure to satisfy continued listing rule

Kyntra Bio, Inc. filed an 8-K with the SEC on 2026-10-06 under Item 3.01, covering a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing.

Detected & updated continuously · Source: Nebula